228 related articles for article (PubMed ID: 15883478)
21. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
[TBL] [Abstract][Full Text] [Related]
22. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
[TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
24. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
[TBL] [Abstract][Full Text] [Related]
25. [Severe polymyositis with simvastatin use].
Riesco-Eizaguirre G; Arpa-Gutiérrez FJ; Gutiérrez M; Toribio E
Rev Neurol; 2003 Nov 16-30; 37(10):934-6. PubMed ID: 14634922
[TBL] [Abstract][Full Text] [Related]
26. [Effects of aggressive therapy with simvastatin in patients with acute coronary syndrome and initially normal level of LDLP cholesterol on cardiovascular outcomes (LAOKOON). Pilot randomized trial].
Arutiunov GP; Kartseva TP; Voevodina NIu; Daĭter II; Malanichev RV; Marfunina AA; Nakhaev VI; Rozanov AV; Rylova AK; Stepanova LV
Ter Arkh; 2005; 77(9):53-60. PubMed ID: 16281491
[TBL] [Abstract][Full Text] [Related]
27. Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
Olkinuora JT; Viikari J; Vanhanen H; Makkonen N; Kalliomäki T
Scand Cardiovasc J; 2006 Jun; 40(3):160-6. PubMed ID: 16798663
[TBL] [Abstract][Full Text] [Related]
28. Methomyl-induced severe acute pancreatitis: possible etiological association.
Makrides C; Koukouvas M; Achillews G; Tsikkos S; Vounou E; Symeonides M; Christodoulides P; Ioannides M
JOP; 2005 Mar; 6(2):166-71. PubMed ID: 15767733
[TBL] [Abstract][Full Text] [Related]
29. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
[TBL] [Abstract][Full Text] [Related]
30. Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients.
Huang CY; Wu TC; Lin WT; Leu HB; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2006 Feb; 36(2):76-84. PubMed ID: 16436088
[TBL] [Abstract][Full Text] [Related]
31. Statin pretreatment in experimental acute pancreatitis.
Almeida JL; Sampietre SN; Mendonça Coelho AM; Trindade Molan NA; Machado MC; Monteiro da Cunha JE; Jukemura J
JOP; 2008 Jul; 9(4):431-9. PubMed ID: 18648134
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
[TBL] [Abstract][Full Text] [Related]
33. Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.
Findling O; Meier N; Sellner J; Nedeltchev K; Arnold M
Neurology; 2008 Oct; 71(15):e34-7. PubMed ID: 18838657
[No Abstract] [Full Text] [Related]
34. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
[TBL] [Abstract][Full Text] [Related]
35. Pravastatin: a potential cause for acute pancreatitis.
Tsigrelis C; Pitchumoni CS
World J Gastroenterol; 2006 Nov; 12(43):7055-7. PubMed ID: 17109506
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
37. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
[TBL] [Abstract][Full Text] [Related]
38. Long-term statin therapy appears safe.
Harv Heart Lett; 1999 Aug; 9(12):6-7. PubMed ID: 10402353
[No Abstract] [Full Text] [Related]
39. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management.
Chyka PA; Erdman AR; Christianson G; Wax PM; Booze LL; Manoguerra AS; Caravati EM; Nelson LS; Olson KR; Cobaugh DJ; Scharman EJ; Woolf AD; Troutman WG; ;
Clin Toxicol (Phila); 2007; 45(2):95-131. PubMed ID: 17364628
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin + ezetimibe: a combination with no proven advantages.
Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
